Clinical Trial Update: Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer [Phase 1]

View source ↗

Summary

Phase I trial evaluating bevacizumab and temsirolimus in combination with carboplatin, paclitaxel, or sorafenib for advanced cancer. The study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Sorafenib (Sorafenib)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING